During PBO's apprearance before the Committee 17 October 2017, the Committee requested additional analysis of the $3.9 billion spent on drugs not listed on Quebec's formulary.
Follow-up Analysis to Costing Analysis of a National Pharmacare Program
During PBO's apprearance before the Committee 17 October 2017, the Committee requested additional analysis of the $3.9 billion spent on drugs not listed on Quebec's formulary.
Follow-up Analysis to Costing Analysis of a National Pharmacare Program
This paper estimates the cost to the federal government of implementing this particular framework for Pharmacare.
Figure 1-3 updated 2017-11-07